• 1. Synthesis and tautomerization of hydroxylated isoflavones bearing heterocyclic hemi-aminals
  Mykhaylo S. Frasinyuk,Svitlana P. Bondarenko,Volodymyr P. Khilya,Chunming Liu,David S. Watt,Vitaliy M. Sviripa Org. Biomol. Chem. 2015 13 1053
• 2. Bis(styrene)bis(triphenylphosphine)ruthenium(0) and its reactions with triphenylphosphine and with alkenes
  Bruno N. Chaudret,David J. Cole-Hamilton,Geoffrey Wilkinson J. Chem. Soc. Dalton Trans. 1978 1739
• 3. Nitroxide radicals. Part VI. Stability of meta- and para-alkyl substituted phenyl-t-butylnitroxides
  A. Calder,A. R. Forrester J. Chem. Soc. C 1969 1459
• 4. Effect of hydrogen bonding on the methyl conformation of thioacetamide: an ab initio study
  Fabio Ramondo,Luigi Bencivenni J. Chem. Soc. Perkin Trans. 2 1994 1985

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Latest Research on Benzene,[(3-methylbutoxy)methyl]- (CAS: 122-73-6) in Chemical Biology and Pharmaceutical Applications

Benzene,[(3-methylbutoxy)methyl]-, with the CAS registry number 122-73-6, is a chemical compound that has garnered attention in recent studies due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its benzene ring substituted with a (3-methylbutoxy)methyl group, has been explored for its unique physicochemical properties and biological activities. The latest research highlights its role as an intermediate in organic synthesis and its emerging significance in drug discovery and development.

Recent studies have focused on the synthesis and characterization of Benzene,[(3-methylbutoxy)methyl]- to understand its reactivity and potential as a building block for more complex molecules. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to elucidate its structure and purity. These studies are critical for ensuring the compound's suitability in pharmaceutical applications, where consistency and purity are paramount.

In the context of drug discovery, Benzene,[(3-methylbutoxy)methyl]- has been investigated for its potential as a scaffold in the design of novel therapeutic agents. Computational modeling and in vitro assays have revealed its ability to interact with specific biological targets, suggesting its utility in developing inhibitors or modulators for various diseases. For instance, preliminary data indicate its affinity for certain enzyme active sites, which could be leveraged in the treatment of metabolic disorders.

Furthermore, the compound's stability and solubility profiles have been examined to assess its feasibility in formulation development. Researchers have explored its behavior in different solvent systems and under varying pH conditions, providing insights into its potential as a drug candidate or excipient. These findings are particularly relevant for oral and topical formulations, where physicochemical properties significantly influence bioavailability and efficacy.

Another area of interest is the environmental and toxicological impact of Benzene,[(3-methylbutoxy)methyl]-. Recent toxicology studies have aimed to evaluate its safety profile, including acute and chronic exposure effects. These investigations are essential for regulatory compliance and risk assessment, ensuring that the compound can be safely utilized in industrial and pharmaceutical settings. Early results suggest that while the compound exhibits low acute toxicity, further long-term studies are warranted to fully understand its environmental footprint.

In summary, the latest research on Benzene,[(3-methylbutoxy)methyl]- (CAS: 122-73-6) underscores its versatility and potential in chemical biology and pharmaceutical applications. From its role as a synthetic intermediate to its emerging therapeutic possibilities, this compound represents a promising area of study. Future research directions may include more extensive biological testing, optimization of synthetic routes, and exploration of its derivatives to unlock new pharmacological activities.

• 4541-14-4(4-Benzyloxy-1-butanol)
• 588-67-0(Benzyl butyl ether)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)